Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose vision meets a minimum level, measured by a standard eye chart test called ETDRS (a score above 40 letters when tested at 4 metres)
- People who have been diagnosed with dry age-related macular degeneration (AMD) at a specific stage of the disease, known as AREDS grade 2 or 3 (a mid-range stage, not the earliest or most advanced)
- People who are able to communicate clearly with the research team and can understand and follow the study requirements
Who may not be able to join:
- People who have epilepsy
- People who have a neurological disease (a condition affecting the brain or nervous system)
- People who have a psychiatric condition (a mental health diagnosis)
- People who have a herpes virus infection
- People who have a dense cataract (a significant clouding of the lens in the eye)
- People who are pregnant
- People who have other significant eye or retinal diseases in addition to their AMD
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 003909613647135
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Best Corrected Visual Acuity variation; Drusen Volume Variation; Contrast sensitivity variation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.